CRISPR Therapeutics (NasdaqGM:CRSP) experienced a 15.8% increase in its share price over the past month. While specific recent news on the company was not available to credit for this movement, it's ...

CRISPR Therapeutics (CRSP) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

CRISPR Therapeutics CRSP is currently the only company in the world to have secured approval for a CRISPR-based gene therapy ...

Crispr Therapeutics AG ( ($CRSP) ) has risen by 13.29%. Read on to learn why. Crispr Therapeutics AG has seen a notable increase in its stock ...

Forget the hyper-volatile, high-profile stock names. In this environment, lesser-known and less-exciting stocks are apt to ...

For investors still seeking companiies with attractive long-term prospects, let's consider two in the biotech industry: ...

The global CRISPR technology market is expected to witness a growth rate of 16% in the next five years. Continuous ...

CRISPR Therapeutics has begun realizing sales on Casgevy, its first therapy and a joint venture with Vertex Pharmaceuticals. The company has plenty of cash to fund research and development for the ...

Some biotechnology companies, such as CRISPR Therapeutics (NASDAQ: CRSP), hope to use gene editing technology to treat, or even cure, diseases that existing drugs cannot. Where to invest $1,000 ...

CRISPR Therapeutics stock opened at $37.53 on Tuesday. CRISPR Therapeutics has a 52-week low of $30.04 and a 52-week high of $67.88. The firm’s fifty day moving average is $37.14 and its 200 day ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.